Seven people with severe arm weakness from stroke regained meaningful strength through a thin electrode implanted along the neck—a breakthrough that researchers believe could reshape recovery expectations for the nearly 400,000 Americans who develop chronic arm and hand paralysis each year.
The University of Pittsburgh School of Medicine released final results of a pioneering clinical trial showing that cervical epidural spinal cord stimulation can improve arm function even years after stroke, with findings published in Nature Medicine. The approach works by sending targeted electrical signals to sensory nerve fibers in the spinal cord, enhancing communication between the brain and weakened muscles. Though the same class of device has treated chronic pain for decades, this marks the first time it has been deployed to restore arm movement after stroke.
All seven participants in the study experienced an average 32% increase in arm strength, along with improvements in overall arm mobility and a reduction in muscle spasticity—the abnormal stiffness caused by stroke-damaged nerve pathways. Remarkably, these gains came with minimal rehabilitation demand: the intervention required fewer than nine hours of movement-based training over four weeks and caused no discomfort or serious adverse events. "The stimulation works mostly as an assistive technology—when it's on, people can move better," explained Marco Capogrosso, Ph.D., assistant professor of neurological surgery at Pitt and director of the spinal cord stimulation laboratory at Rehab Neural Engineering Labs in the UPMC Rehabilitation Institute. "By stimulating the spinal cord, we can immediately allow residual connections between the brain and the spinal cord to work more efficiently, enabling better movement."
The results expand on earlier findings the team reported in 2023 and confirm that the approach is safe and feasible across participants of different ages, sexes, and racial backgrounds. Researchers observed two distinct types of benefit: all seven participants experienced immediate improvements in strength when stimulation was turned on, regardless of baseline severity, and all seven saw reductions in spasticity over the four-week period.
For many stroke survivors, these incremental gains can unlock everyday abilities that standard rehabilitation rarely achieves. Stroke ranks as the leading cause of adult arm paralysis in the United States, with recovery of arm function consistently ranking as the top unmet clinical need among survivors. George Wittenberg, M.D., Ph.D., professor of neurology and physical medicine and rehabilitation at Pitt's School of Medicine, emphasized the lived significance of modest improvements: "Some of the improvements we measure may look small from the outside, but many stroke survivors are just on the verge of being able to do something important. Even a small change in motor function can be very significant if it helps someone button a shirt, open their hand or return to an activity they care about."
The trial's structure—implanting thin electrodes along the cervical spine to target the region controlling hand and arm movement—reflects years of precision neuroscience work. While this remains an early pilot study of seven participants, the consistency of results across diverse demographics and the absence of serious adverse events suggest a pathway toward broader clinical application. As researchers continue to expand their work, the possibility that profound paralysis from stroke might be reversible, even years later, offers hope to millions living with one of the nation's most disabling conditions.